share_log
Reuters ·  Apr 29 06:00
Bristol-Myers Squibb Co - Under Terms of Agreement, Repertoire Will Receive up to $1.8 Bln for Achieving Development, Regulatory Commercial Milestones
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment